IMR Press / CEOG / Volume 43 / Issue 1 / DOI: 10.12891/ceog2018.2016

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Pregnancy after heart surgery – challenges
Show Less
1 Medical School University of Belgrade, Belgrade
2 Clinic for Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade (Serbia)
Clin. Exp. Obstet. Gynecol. 2016, 43(1), 48–51; https://doi.org/10.12891/ceog2018.2016
Published: 10 February 2016
Abstract

Purpose: Advances in cardiac surgery significantly improve life expectancy and quality of life of patients with congenital or acquired heart disease. Materials and Methods: The present study included 146 pregnant women who had antenatal care and gave birth at the Institute of Gynecology and Obstetrics in an interval of ten years from 1994-2004. Patients were divided in four groups according to the type of heart surgery. Group I included four patients with surgically corrected coarctation of the aorta. Group II included 27 patients with correction of the ostial stenosis. Group III had 68 patients with correction of congenital heart diseases, and group IV had 47 patients with artificial heart valves. Results: There was 4% of heart failure after delivery. The incidence of hemorrhagic complications during pregnancy was 2.7% and 4.1% after delivery. The incidence of thromboembolic complications after delivery was 6%. Four newborns died, one of hydrocephalus and three of hypoxic ischemic encephalopathy. Two patients died. Conclusion: Patients with artificial heart valves need an enhanced level of medical care during pregnancy and labor.
Keywords
Congenital heart disease
Heart surgery
Pregnancy
Anticoagulation therapy
Share
Back to top